IRE

PROCEDURE2 trials

Sponsors

The University of Texas Health Science Center, Houston, Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery

Conditions

Hepatocellular CancerMetastatic Liver CancerUnresectable Pancreatic Cancer

Unknown Phase

Prospective Tumor Response Evaluation

TerminatedNCT02787954

The University of Texas Health Science Center, HoustonHepatocellular Cancer, Metastatic Liver Cancer

Start: 2016-01-31End: 2017-04-30Updated: 2018-10-18

Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer

Ole Thorlacius-Ussing, MD, DMSc, Professor of SurgeryUnresectable Pancreatic Cancer

Start: 2019-05-01End: 2024-05-31Target: 30Updated: 2021-04-01